Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass
Sponsor: Second Xiangya Hospital of Central South University
A NA clinical study on Osteoporosis, Osteopenia, this trial is completed. The trial is conducted by Second Xiangya Hospital of Central South University and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2022 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Apr 2022 — Jul 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Apr 2020 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Second Xiangya Hospital of Central South University
For direct contact, visit the study record on ClinicalTrials.gov .